Plexus (NASDAQ:PLXS) share price breaks above two hundred day moving average - should you sell? October 29, 2026 Key points. * Plexus shares climbed above their 200-day moving average, reaching $241.95 and last trading at $239.34, although the 50-day average remains higher at $247.99. * Analysts remain broadly bullish, with a consensus "Buy" rating and an average price target of $276.86; individual targets from KeyCorp and Needham reached $300 and $310, respectively. * Plexus reported stronger-than-expected quarterly results, posting $2.84 in EPS and $1.43 billion in revenue, with revenue up 34.9% year over year. Insiders sold 9,000 shares during the quarter, while institutional investors own 94.45% of the stock. * MarketBeat previews top five stocks to own in November. Shares of Plexus Corp. (NASDAQ:PLXS - Get Free Report) passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $238.91 and traded as high as $241.95. Plexus shares last traded at $239.34, with a volume of 699,436 shares traded. Analysts set new price targets. A number of analysts have commented on PLXS shares. Zacks Research raised shares of Plexus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 11th. KeyCorp raised Plexus from a "sector weight" rating to an "overweight" rating and set a $300.00 price target on the stock in a research report on Monday, September 21st. Weiss Ratings cut Plexus from a "buy (b-)" rating to a "hold (c+)" rating in a report on Friday, October 23rd. Needham & Company LLC reiterated a "buy" rating and set a $310.00 price objective on shares of Plexus in a report on Friday, August 14th. Finally, Wall Street Zen lowered Plexus from a "buy" rating to a "hold" rating in a research report on Saturday, October 24th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $276.86. Plexus price performance. The company's fifty day moving average is $247.99 and its 200 day moving average is $238.91. The firm has a market cap of $6.40 billion, a price-to-earnings ratio of 35.30 and a beta of 0.88. The company has a quick ratio of 0.72, a current ratio of 1.49 and a debt-to-equity ratio of 0.06. Plexus (NASDAQ:PLXS - Get Free Report) last issued its quarterly earnings results on Wednesday, October 28th. The technology company reported $2.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.55 by $0.29. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same period in the previous year, the business earned $2.14 EPS. The company's revenue was up 34.9% compared to the same quarter last year. On average, equities research analysts predict that Plexus Corp. will post 7.13 EPS for the current year. Insider activity at Plexus. In related news, Director Karen Rapp sold 500 shares of Plexus stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $240.87, for a total value of $120,435.00. Following the sale, the director owned 7,535 shares of the company's stock, valued at approximately $1,814,955.45. The trade was a 6.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael V. Schrock sold 4,000 shares of the company's stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $275.00, for a total value of $1,100,000.00. Following the sale, the director owned 40,329 shares in the company, valued at $11,090,475. The trade was a 9.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 9,000 shares of company stock valued at $2,319,260. 1.78% of the stock is owned by insiders. Institutional inflows and outflows. Several institutional investors have recently modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of Plexus during the 2nd quarter worth approximately $32,000. Root Financial Partners LLC acquired a new stake in shares of Plexus in the 3rd quarter valued at about $32,000. Kilter Group LLC acquired a new stake in shares of Plexus in the 2nd quarter valued at about $40,000. Integrated Wealth Concepts LLC acquired a new position in Plexus during the 2nd quarter worth approximately $51,000. Finally, Pension & Wealth Management Advisors Inc. bought a new position in Plexus in the third quarter worth approximately $45,000. 94.45% of the stock is currently owned by institutional investors and hedge funds. About Plexus. Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services. Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Plexus, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list. While Plexus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys. Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Continue following MarketBeat

Plexus (NASDAQ:PLXS) shares down 8.9% - should you sell? October 29, 2026 Key points. * Plexus reported strong fiscal 2026 results: Fourth-quarter adjusted EPS of $2.84 and revenue of $1.427 billion surpassed estimates, while full-year revenue rose 23% to a record $4.965 billion. Management also raised its long-term margin target and authorized a new $100 million share-repurchase program. * Shares fell about 9% as investors focused on near-term headwinds: Fiscal Q1 2027 guidance implies lower adjusted EPS and operating margins, while full-year free cash flow was negative $28.9 million and customer concentration increased. * Wall Street remains broadly positive but insider selling adds caution: Analysts maintain a consensus "Buy" rating with an average price target of $276.86, although executives and directors have recently sold shares, including a 1,500-share sale by the CEO. * Five stocks to consider instead of Plexus. Plexus Corp. (NASDAQ:PLXS - Get Free Report) shares were down 8.9% during trading on Thursday. The company traded as low as $223.70 and last traded at $217.9980. 72,950 shares were traded during trading, a decline of 77% from the average session volume of 311,615 shares. The stock had previously closed at $239.34. Plexus news summary. Here are the key news stories impacting Plexus this week: * Fiscal Q4 adjusted EPS was $2.84, above the roughly $2.55-$2.57 analyst consensus, while revenue of $1.427 billion exceeded expectations near $1.36 billion. Revenue increased 34.9% year over year, and adjusted operating margin reached 6.7%. * Fiscal 2026 revenue reached a record $4.965 billion, up 23% from the prior year, while adjusted EPS rose to $8.97 from $7.43. Plexus also won 36 manufacturing programs representing $290 million in annualized revenue when fully ramped and expanded its qualified opportunity pipeline to $4.9 billion. * Management introduced a higher long-term non-GAAP operating-margin goal of 6.5% to 7.0%, expects at least $100 million of fiscal 2027 free cash flow, and has authorized a new $100 million share-repurchase program. * Technical momentum had been improving: PLXS shares recently crossed above their 200-day moving average, a signal that can attract technical buyers. * Fiscal Q1 2027 guidance implies a sequential slowdown in adjusted EPS, with a midpoint of approximately $2.54 versus $2.84 in Q4. Adjusted operating-margin guidance of 6.0%-6.4% is also below the latest 6.7% result, potentially disappointing investors expecting continued near-term acceleration. * Full-year free cash flow was negative $28.9 million because of heavy capital investment and working-capital needs. Customer concentration also increased, with the top 10 customers accounting for 56% of Q4 revenue. * Reported insider activity has been heavily weighted toward selling, including multiple sales by Chief Executive Officer Todd Kelsey, which may add to investor caution after the stock's substantial advance. Wall Street analyst weigh in. Several research analysts recently commented on the stock. Weiss Ratings lowered shares of Plexus from a "buy (b-)" rating to a "hold (c+)" rating in a report on Friday, October 23rd. Wall Street Zen downgraded Plexus from a "buy" rating to a "hold" rating in a report on Saturday, October 24th. Zacks Research upgraded shares of Plexus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 11th. KeyCorp upgraded shares of Plexus from a "sector weight" rating to an "overweight" rating and set a $300.00 price objective on the stock in a research note on Monday, September 21st. Finally, Needham & Company LLC reiterated a "buy" rating and set a $310.00 price target on shares of Plexus in a research report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $276.86. Discover more MarketBeat All Access MarketBeat Research Tools Plexus stock down 8.5%. The stock has a market cap of $5.86 billion, a P/E ratio of 32.20 and a beta of 0.88. The company has a quick ratio of 0.72, a current ratio of 1.49 and a debt-to-equity ratio of 0.06. The business has a 50-day simple moving average of $247.99 and a 200-day simple moving average of $238.91. Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings data on Wednesday, October 28th. The technology company reported $2.84 EPS for the quarter, beating analysts' consensus estimates of $2.55 by $0.29. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.36 billion. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The firm's revenue for the quarter was up 34.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.14 earnings per share. Analysts expect that Plexus Corp. will post 7.13 EPS for the current year. Insider buying and selling. In other Plexus news, CEO Todd Kelsey sold 1,500 shares of the business's stock in a transaction on Wednesday, October 21st. The stock was sold at an average price of $239.16, for a total value of $358,740.00. Following the transaction, the chief executive officer owned 62,888 shares of the company's stock, valued at approximately $15,040,294.08. The trade was a 2.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael V. Schrock sold 4,000 shares of the business's stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the completion of the transaction, the director directly owned 40,329 shares of the company's stock, valued at approximately $11,090,475. This represents a 9.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 9,000 shares of company stock worth $2,319,260 in the last three months. Insiders own 1.78% of the company's stock. Institutional investors weigh in on Plexus. Several hedge funds have recently bought and sold shares of the company. Vise Technologies Inc. increased its position in Plexus by 45.1% during the third quarter. Vise Technologies Inc. now owns 1,598 shares of the technology company's stock worth $417,000 after acquiring an additional 497 shares during the period. VestGen Advisors LLC bought a new position in shares of Plexus in the 3rd quarter valued at $378,000. Moody Aldrich Partners LLC lifted its holdings in shares of Plexus by 4.1% in the third quarter. Moody Aldrich Partners LLC now owns 15,834 shares of the technology company's stock worth $4,132,000 after acquiring an additional 629 shares during the last quarter. Smith Group Asset Management LLC boosted its position in Plexus by 1.6% in the third quarter. Smith Group Asset Management LLC now owns 4,536 shares of the technology company's stock valued at $1,184,000 after buying an additional 73 shares in the last quarter. Finally, Signaturefd LLC increased its holdings in Plexus by 6.1% in the 3rd quarter. Signaturefd LLC now owns 1,765 shares of the technology company's stock worth $461,000 after purchasing an additional 101 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors and hedge funds. About Plexus. Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services. Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications. Further reading. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Plexus, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list. While Plexus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys. The space race is growing fast, and you don't have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important. Continue following MarketBeat

Plexus Corp. reported record fiscal 2026 revenue of $4.965 billion, up 23% year over year. GAAP diluted earnings per share (EPS) were $7.41, and non-GAAP EPS was $8.97. Fourth-quarter revenue was $1.427 billion, with GAAP EPS of $2.51 and non-GAAP EPS of $2.84. Both beat guidance. The company won 36 manufacturing programs worth $290 million in annualised revenue. For the first quarter of fiscal 2027, Plexus expects revenue of $1.410 billion to $1.460 billion and non-GAAP EPS of $2.46 to $2.62. It set a new non-GAAP operating margin goal of 6.5% to 7.0%, up from 6%. Plexus bought back $85.0 million of shares in fiscal 2026 and approved a new $100 million repurchase programme.